|
Clinical Characteristics (n = 12) |
|
| Characteristics |
Number (%) |
|
|
|
| Mean age at prophylactic surgery (range) |
43 (34–65) |
| BMI (SD) |
22.7 ± 3.1* |
| Race |
|
| White, Non-Ashkenazie Jewish |
10 (83.3) |
| Ashkenazie Jewish |
1 (8.3) |
| Hispanic |
1 (8.3) |
| Personal previous history of breast cancer |
10 (83.3) |
| Primary |
9 (75) |
| Primary with local recurrence |
1 (8.3) |
| Personal history of ovarian cancer |
0 (0) |
| Family history of breast cancer |
11 (91.6) |
| First degree relatives with breast cancer |
9 (75) |
| Family history of ovarian cancer |
2 (16.6) |
| First degree relatives with ovarian cancer |
1 (8.3) |
| Smoking |
2 (16.66) |
| Parity |
|
| 1 live birth |
2 (16.66) |
| 2 live birth |
7 (58.33) |
| 3 live birth |
3 (25) |
| Menopausal Status |
|
| Premenopausal |
7 (58.33) |
| Postmenopausal |
5 (41.66) |
| Due to chemotherapy |
1 (8.33) |
| Due to use of tamoxifen |
1 (8.33) |
| Due to previous hysterectomy |
2 (16.66) |
| Natural menopause |
1 (8.33) |
|
*Values are presented as average ± standard deviation | |
Batista et al. BMC Cancer 2008 8:101 doi:10.1186/1471-2407-8-101 |
|